Latest News and Press Releases

SAN DIEGO, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded US Patent No. 10,046,025, providing non-invasive delivery of cyclic peptide drugs....

SAN DIEGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded European Patent No. EP2381773(B1) and Canadian Patent No. 2,748,268, providing fast...

SAN DIEGO, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 9,895,444 providing non-invasive metered nasal spray delivery of multiple...

SAN DIEGO, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Aegis Therapeutics has developed a metered nasal spray formulation of hydromorphone having rapid onset of drug action (approximately 1 min. with a Tmax...

SAN DIEGO, June 28, 2017 (GLOBE NEWSWIRE) -- Aegis Therapeutics announces positive Phase 2 results of DFN-02 using Intravail® technology. Dr. Reddy's Laboratories in collaboration with Promius...

SAN DIEGO, June 22, 2017 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded Korean Patent No. 1719008, providing fast acting formulations for triptans, a class of...

SAN DIEGO, CA--(Marketwired - May 10, 2017) - Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 9,642,913, the fourth patent providing non-invasive metered nasal spray...

SAN DIEGO, CA--(Marketwired - September 22, 2016) - Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 9,446,134 providing non-invasive metered nasal spray delivery of...

SAN DIEGO, CA--(Marketwired - August 30, 2016) - Aegis Therapeutics LLC announced today that it has been awarded Hong Kong Patent No. HK1164059 providing fast acting formulations for triptans, a...

SAN DIEGO, CA--(Marketwired - March 17, 2016) - Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 9,283,280, its eighth patent, third in the US, providing fast...